UNITED HEALTH PRODUCTS, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.9K | $183.2K | $242.0K | $53.3K | $162.7K | $3.1K | — | — |
| Cost of Revenue | $22.3K | $101.0K | $117.9K | $27.5K | $83.0K | — | — | — |
| Gross Profit | $12.6K | $82.2K | $124.1K | $25.8K | $79.7K | $3.1K | — | — |
| Gross Margin | 36.1% | 44.9% | 51.3% | 48.3% | 49.0% | 100.0% | — | — |
| Operating Expenses | ||||||||
| Research & Development | $77.0K | $19.9K | — | — | — | — | — | — |
| SG&A Expense | $1.8M | $990.7K | $641.6K | $2.6M | $2.1M | $1.2M | $107.0K | $1.2M |
| Operating Income | $-1.9M | $-928.4K | $-517.5K | $-2.6M | $-2.1M | $-1.3M | $-207.0K | $-1.3M |
| Operating Margin | -5,439.2% | -506.9% | -213.8% | -4,848.7% | -1,286.1% | -43,029.6% | — | — |
| Interest Expense | $0 | $39.5K | $18.3K | $9.1K | $52.1K | $68.7K | $-74.4K | $271.0K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | — | — | — | — | — | — |
| Net Income | $-5.4M | $-1.5M | $-535.7K | $-2.6M | $-2.1M | $-1.1M | $-281.4K | $-1.6M |
| Net Margin | -15,490.2% | -800.8% | -221.4% | -4,865.9% | -1,318.2% | -36,809.3% | — | — |
| EPS (Basic) | $-0.04 | $-0.01 | $0.00 | $-0.02 | $-0.02 | $-0.01 | $0.00 | $-0.02 |
| EPS (Diluted) | $-0.03 | $-0.01 | — | — | $-0.02 | $-0.01 | $0.00 | $-0.02 |
| Shares Outstanding (Basic) | 171.8M | 165.0M | 153.8M | 148.0M | 108.2M | 102.3M | 84.6M | 80.8M |
| Shares Outstanding (Diluted) | 171.8M | 165.0M | 153.8M | 148.0M | 108.2M | 102.3M | 84.6M | 80.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |